世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

欧州のグルコースモニタリングシステム市場予測 2019-2028年

EUROPE GLUCOSE MONITORING SYSTEM MARKET FORECAST 2019-2028

 

出版社 出版年月電子版価格 ページ数
Inkwood Research
インクウッドリサーチ
2020年5月US$1,250
シングルユーザライセンス(印刷不可PDF)
165

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートは欧州のグルコースモニタリングシステム市場を分析・予測したInkwood Researchの市場調査報告書です。

Overview

KEY FINDINGS

The Europe glucose monitoring system CGMS market is anticipated to register a CAGR of 23.00%, and the SMBG market is predicted to record growth at a CAGR of 5.40% during the forecast period of 2019-2028. The factors propelling market growth in the region are enhanced healthcare infrastructure and the introduction of patient-specific glucose monitoring devices in Western Europe.

MARKET INSIGHTS

The Europe glucose monitoring system market is analyzed on the basis of the market performance in countries such as France, Germany, the UK, Poland, Italy, Belgium, Russia, and the rest of Europe. In Italy, 5.3% of the total population is suffering from diabetes. The total per capita expenditure on healthcare has recently increased to $xx. The SSN ensures the general objectives and fundamental principles of the national healthcare system covers all necessary treatment. The major growth factors for branded pharmaceuticals are the growing use of high-value treatment by the elderly population, high level of brand loyalty, and increasing budget expenditure on pharmaceuticals. In countries like Belgium, in 2017, 6.1% of the people were diagnosed with diabetes as per an article. The increasing incidence of diabetes due to the aging population is expected to stimulate market growth.
In Poland, the number of people suffering from diabetes will rise to 2.2-2.5 million by 2030, according to the WHO. Gluucoactive, Polish medical device company has developed GlucoStation, a blood glucose measuring device. The surge in the diabetic population will augment market growth in the region. In the rest of Europe, though, the market is very small compared to the US, GMS has been accepted well in the rest of European markets, and obtained the CE mark in the European countries.

COMPETITIVE INSIGHTS

Some of the prominent companies functioning in the market are Nemaura Medical Inc, Abbott Diagnostic, Becton, Dickinson, and Company, B. Braun Melsungen AG, Johnson & Johnson, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments



目次

Table of Contents

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARIES
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. RISE IN THE INCIDENCE OF DIABETES
3.2.2. INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
3.2.3. TECHNOLOGY INTEGRATION
3.2.4. INCREASING CGMS AND SMBG AFFORDABILITY
3.2.5. TECHNOLOGICAL ADVANCES IN GMS DEVICES
3.2.6. AWARENESS AMONG THE GENERAL POPULATION
3.3. KEY RESTRAINTS
3.3.1. HINDRANCE FROM GOVERNMENT REGULATIONS
3.3.2. INADEQUATE REIMBURSEMENT OPTIONS FOR CONTINUOUS GLUCOSE MONITORING DEVICES
3.3.3. LACK OF AWARENESS OF THE DIAGNOSTIC OPPORTUNITIES
3.3.4. INTENSE COMPETITION AMONG VENDORS
3.3.5. INACCURACY IN READING OF GMS DEVICES
4. KEY ANALYTICS
4.1. PORTER’S FIVE FORCE ANALYSIS
4.1.1. THREAT OF NEW ENTRY
4.1.2. THREAT OF SUBSTITUTION
4.1.3. BUYER’S POWER
4.1.4. SUPPLIER’S POWER
4.1.5. COMPETITIVE RIVALRY
4.2. KEY BUYING CRITERIA
4.3. REGULATION OF BLOOD SUGAR
4.4. VALUE CHAIN ANALYSIS
4.5. OPPORTUNITY MATRIX
4.6. VENDOR LANDSCAPE
4.7. KEY INVESTMENT INSIGHTS
5. CGMS MARKET BY COMPONENT TYPE
5.1. SENSORS
5.2. TRANSMITTER AND RECEIVERS
5.3. INTEGRATED INSULIN PUMPS
6. CGMS MARKET BY END-USER
6.1. HOME SETTINGS
6.2. DIAGNOSTICS AND CLINICAL
6.3. HOSPITAL
7. CGMS MARKET BY DEMOGRAPHICS
7.1. ADULT POPULATION (>14YEARS)
7.2. CHILD POPULATION (?14YEARS)
8. SMBG MARKET OVERVIEW
9. SMBG MARKET BY COMPONENT TYPE
9.1. TEST STRIPS
9.2. GLUCOSE METER
9.3. LANCETS
10. SMBG MARKET BY END-USER
10.1. HOME SETTINGS
10.2. CLINICAL
10.3. HOSPITAL
11. SMBG MARKET BY APPLICATION
11.1. TYPE 1 DIABETES
11.2. TYPE 2 DIABETES
11.3. GESTATIONAL DIABETES
12. GEOGRAPHICAL ANALYSIS
12.1. EUROPE
12.1.1. GERMANY
12.1.1.1. GERMANY HEALTH AND HEALTHCARE
12.1.1.2. GERMANY PHARMACEUTICAL MARKET
12.1.2. THE UNITED KINGDOM
12.1.2.1. THE UNITED KINGDOM HEALTH AND HEALTHCARE
12.1.2.2. THE UNITED KINGDOM HEALTHCARE PROVISION
12.1.2.3. THE UNITED KINGDOM PRIVATE SECTOR INVOLVEMENT
12.1.2.4. THE UNITED KINGDOM PHARMACEUTICALS
12.1.3. FRANCE
12.1.3.1. FRANCE HEALTH AND HEALTHCARE
12.1.3.2. FRANCE HEALTHCARE PROVISION
12.1.4. RUSSIA
12.1.4.1. RUSSIA HEALTH AND HEALTHCARE
12.1.4.2. RUSSIA PHARMACEUTICAL SERVICES
12.1.5. ITALY
12.1.5.1. ITALY HEALTH AND HEALTHCARE
12.1.5.2. ITALY HEALTHCARE PROVISION
12.1.5.3. ITALY PHARMACEUTICAL MARKET
12.1.6. BELGIUM
12.1.7. POLAND
12.1.8. REST OF EUROPE (ROE)
13. COMPANY PROFILES
13.1. ABBOTT
13.2. APEX BIOTECHNOLOGY CORPORATION
13.3. ARKRAY INC
13.4. ASCENSIA
13.5. B BRAUN MELSUNGEN AG
13.6. BECTON DICKINSON AND COMPANY
13.7. DEXCOM
13.8. GLYSENS INC
13.9. INSULET CORP
13.10. I-SENS INC
13.11. JOHNSON AND JOHNSON
13.12. MEDTRONIC
13.13. MOREPEN LABORATORIES LTD
13.14. NEMAURA MEDICAL INC
13.15. ROCHE DIAGNOSTICS
13.16. SENSEONICS INC
13.17. TANDEM DIABETES CARE
13.18. TERUMO
13.19. WOCKHARDT
13.20. YPSOMED

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - GLUCOSE MONITORING SYSTEM
TABLE 2: DIABETES PREVALENCE IN EUROPE 2015-2040 (MILLIONS)
TABLE 3: EUROPE CGMS MARKET, BY COMPONENT TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 4: EUROPE CGMS MARKET, BY COMPONENT TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 5: EUROPE CGMS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 6: EUROPE CGMS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 7: EUROPE CGMS MARKET, BY DEMOGRAPHICS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 8: EUROPE CGMS MARKET, BY DEMOGRAPHICS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 9: IMPORTANT ASPECTS FOR THE USE OF SMBG DEVICES IN HOME-CARE SETTINGS
TABLE 10: PRODUCT MATRIX FOR LANCETS
TABLE 11: EUROPE SMBG MARKET, BY COMPONENT TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 12: EUROPE SMBG MARKET, BY COMPONENT TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 13: EUROPE SMBG MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 14: EUROPE SMBG MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 15: EUROPE SMBG MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 16: EUROPE SMBG MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 17: EUROPE CGMS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 18: EUROPE CGMS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 19: EUROPE SMBG MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 20: EUROPE SMBG MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 21: AVERAGE PRICES IN GERMANY FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER
TABLE 22: GERMANY SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
TABLE 23: AVERAGE PRICES IN UK FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER
TABLE 24: THE UNITED KINGDOM SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

List of Figures

LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: VALUE CHAIN OF CGMS MARKET
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: KEY INVESTMENT INSIGHTS
FIGURE 6: EUROPE CGMS MARKET, BY COMPONENT TYPE, IN 2019
FIGURE 7: EUROPE CGMS MARKET, BY SENSORS, 2019-2028 (IN $ MILLION)
FIGURE 8: EUROPE CGMS MARKET, BY TRANSMITTER AND RECEIVERS, 2019-2028 (IN $ MILLION)
FIGURE 9: EUROPE CGMS MARKET, BY INTEGRATED INSULIN PUMPS, 2019-2028 (IN $ MILLION)
FIGURE 10: EUROPE CGMS MARKET, BY END-USER, IN 2019
FIGURE 11: EUROPE CGMS MARKET, BY HOME SETTINGS, 2019-2028 (IN $ MILLION)
FIGURE 12: EUROPE CGMS MARKET, BY DIAGNOSTICS AND CLINICAL, 2019-2028 (IN $ MILLION)
FIGURE 13: EUROPE CGMS MARKET, BY HOSPITAL, 2019-2028 (IN $ MILLION)
FIGURE 14: EUROPE CGMS MARKET, BY DEMOGRAPHICS, IN 2019
FIGURE 15: EUROPE CGMS MARKET, BY ADULT POPULATION (>14YEARS), 2019-2028 (IN $ MILLION)
FIGURE 16: EUROPE CGMS MARKET, BY CHILD POPULATION (?14YEARS), 2019-2028 (IN $ MILLION)
FIGURE 17: EUROPE SMBG MARKET, BY COMPONENT TYPE, IN 2019
FIGURE 18: EUROPE SMBG MARKET, BY TEST STRIPS, 2019-2028 (IN $ MILLION)
FIGURE 19: EUROPE SMBG MARKET, BY GLUCOSE METER, 2019-2028 (IN $ MILLION)
FIGURE 20: EUROPE SMBG MARKET, BY LANCETS, 2019-2028 (IN $ MILLION)
FIGURE 21: EUROPE SMBG MARKET, BY END-USER, IN 2019
FIGURE 22: EUROPE SMBG MARKET, BY HOME SETTINGS, 2019-2028 (IN $ MILLION)
FIGURE 23: EUROPE SMBG MARKET, BY CLINICAL, 2019-2028 (IN $ MILLION)
FIGURE 24: EUROPE SMBG MARKET, BY HOSPITAL, 2019-2028 (IN $ MILLION)
FIGURE 25: EUROPE SMBG MARKET, BY APPLICATION, IN 2019
FIGURE 26: EUROPE SMBG MARKET, BY TYPE 1 DIABETES, 2019-2028 (IN $ MILLION)
FIGURE 27: EUROPE SMBG MARKET, BY TYPE 2 DIABETES, 2019-2028 (IN $ MILLION)
FIGURE 28: EUROPE SMBG MARKET, BY GESTATIONAL DIABETES, 2019-2028 (IN $ MILLION)
FIGURE 29: EUROPE CGMS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
FIGURE 30: EUROPE SMBG MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
FIGURE 31: GERMANY CGMS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 32: GERMANY SMBG MARKET, 2019-2028 (IN $ MILLION)
FIGURE 33: THE UNITED KINGDOM CGMS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 34: THE UNITED KINGDOM SMBG MARKET, 2019-2028 (IN $ MILLION)
FIGURE 35: FRANCE CGMS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 36: FRANCE SMBG MARKET, 2019-2028 (IN $ MILLION)
FIGURE 37: RUSSIA CGMS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 38: RUSSIA SMBG MARKET, 2019-2028 (IN $ MILLION)
FIGURE 39: ITALY CGMS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 40: ITALY SMBG MARKET, 2019-2028 (IN $ MILLION)
FIGURE 41: BELGIUM CGMS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 42: BELGIUM SMBG MARKET, 2019-2028 (IN $ MILLION)
FIGURE 43: POLAND CGMS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 44: POLAND SMBG MARKET, 2019-2028 (IN $ MILLION)
FIGURE 45: REST OF EUROPE CGMS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 46: REST OF EUROPE SMBG MARKET, 2019-2028 (IN $ MILLION)

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る